Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AbbVie Inc. stock logo
ABBV
AbbVie
$294.18
-0.3%
$276.27
$190.75
▼
$302.93
$520.47B0.25.28 million shs4.71 million shs
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$107.33
-1.1%
$103.91
$81.97
▼
$132.02
$185.75B0.549.56 million shs8.64 million shs
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$282.62
-1.1%
$267.12
$195.90
▼
$290.25
$682.52B0.227.47 million shs7.94 million shs
Mondelez International, Inc. stock logo
MDLZ
Mondelez International
$67.54
$62.68
$51.20
▼
$68.92
$84.25B0.347.96 million shs10.49 million shs
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AbbVie Inc. stock logo
ABBV
AbbVie
0.00%+1.26%+3.46%+17.82%+27.00%
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.00%-1.30%+3.63%-1.88%-16.84%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.00%+3.49%+11.83%+8.90%+45.80%
Mondelez International, Inc. stock logo
MDLZ
Mondelez International
0.00%+2.30%+5.68%+8.62%+18.78%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AbbVie Inc. stock logo
ABBV
AbbVie
$294.18
-0.3%
$276.27
$190.75
▼
$302.93
$520.47B0.25.28 million shs4.71 million shs
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$107.33
-1.1%
$103.91
$81.97
▼
$132.02
$185.75B0.549.56 million shs8.64 million shs
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$282.62
-1.1%
$267.12
$195.90
▼
$290.25
$682.52B0.227.47 million shs7.94 million shs
Mondelez International, Inc. stock logo
MDLZ
Mondelez International
$67.54
$62.68
$51.20
▼
$68.92
$84.25B0.347.96 million shs10.49 million shs
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AbbVie Inc. stock logo
ABBV
AbbVie
0.00%+1.26%+3.46%+17.82%+27.00%
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.00%-1.30%+3.63%-1.88%-16.84%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.00%+3.49%+11.83%+8.90%+45.80%
Mondelez International, Inc. stock logo
MDLZ
Mondelez International
0.00%+2.30%+5.68%+8.62%+18.78%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AbbVie Inc. stock logo
ABBV
AbbVie
2.83
Moderate Buy$297.851.24% Upside
Abbott Laboratories stock logo
ABT
Abbott Laboratories
2.89
Moderate Buy$118.3210.24% Upside
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
2.73
Moderate Buy$275.92-2.37% Downside
Mondelez International, Inc. stock logo
MDLZ
Mondelez International
2.63
Moderate Buy$69.302.61% Upside

Current Analyst Ratings Breakdown

Latest JNJ, ABT, ABBV, and MDLZ Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
11/16/2026
AbbVie Inc. stock logo
ABBV
AbbVie
Boost Price TargetOverweight$325.00 ➝ $335.00
11/13/2026
Mondelez International, Inc. stock logo
MDLZ
Mondelez International
UpgradeHold (C) ➝ Hold (C+)
11/13/2026
Mondelez International, Inc. stock logo
MDLZ
Mondelez International
Reiterated RatingBuy
11/4/2026
AbbVie Inc. stock logo
ABBV
AbbVie
Set Price Target$315.00
11/2/2026
Mondelez International, Inc. stock logo
MDLZ
Mondelez International
Reiterated RatingNeutral$72.00
11/2/2026
AbbVie Inc. stock logo
ABBV
AbbVie
Reiterated RatingMarket Perform$275.00
11/2/2026
AbbVie Inc. stock logo
ABBV
AbbVie
Boost Price TargetBuy$288.00 ➝ $322.00
11/2/2026
AbbVie Inc. stock logo
ABBV
AbbVie
Boost Price TargetOverweight$300.00 ➝ $340.00
11/2/2026
AbbVie Inc. stock logo
ABBV
AbbVie
Boost Price TargetNeutral$275.00 ➝ $295.00
11/2/2026
AbbVie Inc. stock logo
ABBV
AbbVie
Boost Price TargetOutperform$309.00 ➝ $342.00
11/2/2026
AbbVie Inc. stock logo
ABBV
AbbVie
Boost Price TargetOverweight$310.00 ➝ $346.00
(Data available from 11/16/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AbbVie Inc. stock logo
ABBV
AbbVie
$61.16B8.50$15.13 per share19.44($2.57) per share-114.47
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$44.33B4.19$7.00 per share15.34$29.81 per share3.60
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$94.19B7.22$14.07 per share20.08$33.87 per share8.34
Mondelez International, Inc. stock logo
MDLZ
Mondelez International
$38.54B2.22$4.07 per share16.59$21.06 per share3.21
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AbbVie Inc. stock logo
ABBV
AbbVie
$4.23B$5.8122.9518.361.3415.67%-450.55%16.50%2/3/2027 (Estimated)
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$6.52B$2.6819.9318.131.889.75%18.04%9.09%1/28/2027 (Estimated)
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$26.80B$6.6026.6224.452.8016.20%31.64%13.04%1/26/2027 (Estimated)
Mondelez International, Inc. stock logo
MDLZ
Mondelez International
$2.45B$3.1722.9519.982.6510.22%14.18%5.21%2/2/2027 (Estimated)

Latest JNJ, ABT, ABBV, and MDLZ Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
10/30/2026Q3 2026
AbbVie Inc. stock logo
ABBV
AbbVie
$3.73$3.82+$0.09$2.37$17.32 billion$17.40 billion
10/29/2026Q3 2026
Mondelez International, Inc. stock logo
MDLZ
Mondelez International
$0.7080$0.78+$0.0720$1.02$9.98 billion$9.97 billion
10/21/2026Q3 2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$1.42$1.42N/A$0.53$12.99 billion$13.01 billion
10/13/2026Q3 2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$2.53$2.59+$0.06$0.09$25.38 billion$25.40 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
AbbVie Inc. stock logo
ABBV
AbbVie
$6.922.35%+6.80%119.10%53 Years
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$2.522.35%+10.39%94.03%54 Years
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$5.361.90%+5.25%81.21%64 Years
Mondelez International, Inc. stock logo
MDLZ
Mondelez International
$2.083.08%+10.08%65.62%13 Years

Latest JNJ, ABT, ABBV, and MDLZ Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
10/29/2026
AbbVie Inc. stock logo
ABBV
AbbVie
quarterly$1.822.47%1/15/20271/15/20272/16/2027
10/13/2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
quarterly$1.342.15%11/24/202611/24/202612/8/2026
9/10/2026
AbbVie Inc. stock logo
ABBV
AbbVie
quarterly$1.732.44%10/15/202610/15/202611/16/2026
9/17/2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
quarterly$0.632.4%10/15/202610/15/202611/16/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
AbbVie Inc. stock logo
ABBV
AbbVie
N/A
0.87
0.75
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.57
1.45
1.00
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.44
1.02
0.74
Mondelez International, Inc. stock logo
MDLZ
Mondelez International
0.61
0.62
0.42

Institutional Ownership

CompanyInstitutional Ownership
AbbVie Inc. stock logo
ABBV
AbbVie
70.23%
Abbott Laboratories stock logo
ABT
Abbott Laboratories
75.18%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
69.55%
Mondelez International, Inc. stock logo
MDLZ
Mondelez International
78.32%

Insider Ownership

CompanyInsider Ownership
AbbVie Inc. stock logo
ABBV
AbbVie
0.06%
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.46%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.16%
Mondelez International, Inc. stock logo
MDLZ
Mondelez International
0.45%
CompanyEmployeesShares OutstandingFree FloatOptionable
AbbVie Inc. stock logo
ABBV
AbbVie
57,0001.77 billion1.77 billionOptionable
Abbott Laboratories stock logo
ABT
Abbott Laboratories
115,0001.73 billion1.72 billionOptionable
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
138,2002.41 billion2.40 billionOptionable
Mondelez International, Inc. stock logo
MDLZ
Mondelez International
91,0001.27 billion1.26 billionOptionable

Recent News About These Companies

Why Mondelez Stock Stands Out As Rates Stay Higher For Longer
Mondelez International Reaches a Fresh 52-Week High at $67.54
Mondelez International Inc - Class A
Mondelez International Inc - Class A

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
AbbVie stock logo

AbbVie NYSE:ABBV

$294.18 -0.85 (-0.29%)
Closing price 03:59 PM Eastern
Extended Trading
$294.44 +0.26 (+0.09%)
As of 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; Ubrelvy for the acute treatment of migraine in adults; and Qulipta for episodic and chronic migraine. In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; Janssen Biotech, Inc.; and Genentech, Inc., as well as collaboration with Tentarix Biotherapeutics, LP to develop conditionally-active and multi-specific biologics for oncology and immunology. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

Abbott Laboratories stock logo

Abbott Laboratories NYSE:ABT

$107.33 -1.19 (-1.10%)
Closing price 03:59 PM Eastern
Extended Trading
$108.24 +0.90 (+0.84%)
As of 07:45 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Johnson & Johnson stock logo

Johnson & Johnson NYSE:JNJ

$282.62 -3.13 (-1.09%)
Closing price 03:59 PM Eastern
Extended Trading
$282.94 +0.32 (+0.11%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Mondelez International stock logo

Mondelez International NASDAQ:MDLZ

$67.54 0.00 (0.00%)
Closing price 04:00 PM Eastern
Extended Trading
$67.68 +0.13 (+0.20%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Mondelez International, Inc., through its subsidiaries, manufactures, markets, and sells snack food and beverage products in the Latin America, North America, Asia, the Middle East, Africa, and Europe. It provides biscuits and baked snacks, including cookies, crackers, salted snacks, snack bars, and cakes and pastries; chocolates; and gums and candies, as well as various cheese and grocery, and powdered beverage products. The company's brand portfolio includes Oreo, Ritz, LU, CLIF Bar, and Tate's Bake Shop biscuits and baked snacks, as well as Cadbury Dairy Milk, Milka, and Toblerone chocolate. It serves supermarket chains, wholesalers, supercenters, club stores, mass merchandisers, distributors, convenience stores, gasoline stations, drug stores, value stores, and other retail food outlets through direct store delivery, company-owned and satellite warehouses, distribution centers, third party distributors, and other facilities, as well as through independent sales offices and agents. The company also sells products directly to businesses and consumers through e-retail platforms, retailer digital platforms, as well as through its direct-to-consumer websites and social media platforms. Mondelez International, Inc. was formerly known as Kraft Foods Inc. and changed its name to Mondelez International, Inc. in October 2012. The company was incorporated in 2000 and is headquartered in Chicago, Illinois.